-transparent.png){kind=logo}
One hundred dental surgeons practising in western France were immunized against hepatitis B virus, using the same batch of HEVAC B vaccine from the Pasteur Institute. The vaccine was very well tolerated. Seroconversion at 10 m IU/ml was 94% after 3 injections and 98% after the booster dose. From a kinetic study of anti-HBs antibodies we were able to determine different levels of post-immunization serological response and to classify responders as very good, good and fairly good. The effectiveness of the booster dose was manifest after 10 days. In view of the efficacy and safety of this vaccine, confirmed by other studies in sanitary personnel, we do not hesitate to recommend it to dental surgeons exposed to the disease.
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
January 1983,
Vojnosanitetski pregled,
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
January 1998,
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
December 1981,
La Revue du praticien,
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
January 1982,
Medecine & chirurgie digestives,
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
January 1982,
Infection,
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
January 1984,
ZFA. Zeitschrift fur Allgemeinmedizin,
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
January 2012,
Annals of medical and health sciences research,
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
February 1988,
Revue francaise des prothesistes dentaires,
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
January 1985,
Journal of the American Dental Association (1939),
J Zourbas, and
R Fauchet, and
J Y Le Hesran, and
B Denis
June 2003,
Revista de saude publica,
